Eli Lilly and Company

AI Platform Lead System Engineer

Chester, Maryland, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, AI/ML, Software EngineeringIndustries

Requirements

Candidates should possess a Bachelor’s degree in Computer Science, Engineering, or a related field, and have at least 8 years of experience in software engineering, with a strong focus on system design and architecture. They should demonstrate expertise in designing and developing large-scale IT ecosystems, microservices architectures, and APIs, along with a solid understanding of containerization technologies like Kubernetes.

Responsibilities

As the AI Platform Lead System Engineer, you will lead the design, development, and deployment of a large-scale IT ecosystem to drive innovation in pharmaceutical R&D, providing hands-on technical expertise and guiding a team of engineers. You will be responsible for creating robust technical architectures, developing scalable solutions, ensuring seamless system integration, and implementing containerization solutions. Furthermore, you will collaborate with diverse technical teams to translate business requirements into technical solutions, ensuring optimal system performance, reliability, and security, and driving the adoption of modern engineering practices.

Skills

Microservices architecture
Kubernetes
API development
Containerization
AI/ML pipelines
Model deployment and monitoring
Software development best practices
CI/CD
Troubleshooting complex systems
Team leadership and mentoring

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI